Title:
悪性腫瘍を処置するため組合せ療法
Document Type and Number:
Japanese Patent JP7033061
Kind Code:
B2
Abstract:
Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation using a combination of an inhibitor of a mutant IDH1 enzyme and a DNA demethylating agent.
Inventors:
Agresta, Samuel Buoy.
Biswanadan, Krishnan
Dimartino, George
Chopla, Vivek Salodi Kumar
Macbeth, Kyle Jay.
Knight, Robert Douglas
Kelvin, Raleigh
Shoe, Chian
Biswanadan, Krishnan
Dimartino, George
Chopla, Vivek Salodi Kumar
Macbeth, Kyle Jay.
Knight, Robert Douglas
Kelvin, Raleigh
Shoe, Chian
Application Number:
JP2018519313A
Publication Date:
March 09, 2022
Filing Date:
October 14, 2016
Export Citation:
Assignee:
Agios Pharmaceuticals, Incorporated
Celgene Corporation
Celgene Corporation
International Classes:
A61K31/7068; A61K31/4439; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2015509098A | ||||
| JP2014503597A |
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Morishita Natsuki
Previous Patent: How to make an LED device
Next Patent: Single-stranded CD137 receptor agonist protein
Next Patent: Single-stranded CD137 receptor agonist protein